How to use AOD 9604 AOD 9604 is typically administered via subcutaneous injection, though nasal spray formulations are becoming increasingly available
BPC-157's 15-amino-acid sequence corresponds to a region of body protective compound, a protein identified in human gastric juice
For Convenience-First Users: Capsules Capsule-based BPC157 may appeal to: Supplement users who prefer no needles Individuals experimenting with daily low-dose use Those who understand the trade-off in efficacy However, the majority of capsule products lack the dosing consistency and purity required for therapeutic benefit
Frequency varies by compound typesome peptides or lipotropics might be different
We recently launched our in-app chatbot, Melody, powered by the worlds most powerful AI technology
The compound is supplied as a lyophilized powder of 99% purity, formulated to support reproducible in vitro and in vivo experimental work